Carbapenem-resistant Enterobacterales species and multidrug-resistant Pseudomonas aeruginosa are global health threats. Cefepime–taniborbactam is an investigational β-lactam and β-lactamase inhibitor ...

Uncomplicated urinary tract infections occur when common bacteria infect the lower urinary tract of otherwise healthy females. Any urinary tract infection that does not fit this description is a ...

man-injection-0316 The antibiotic Recarbrio is a combination of imipenem-cilastatin and relebactam. The FDA today approved Recarbrio, an antibiotic injection containing a combination of ...

Urinary tract infections (UTIs) are bacterial infections, and antibiotics continue to be the No. 1 go-to treatment. Most often, these drugs come in the form of oral pills taken over a period of ...

For adults with complicated urinary tract infections, a new drug has been approved by the U.S. Food and Drug Administration. Vabomere is an antibacterial drug that inhibits "certain types of ...

The application includes data from the phase 3 ADAPT-PO trial, which evaluated the efficacy and safety of tebipenem HBr in 868 adults with cUTI or acute pyelonephritis. The Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . IDSA updated UTI guidelines for the first time since 2010. The guidance includes definitions for complicated vs.

Approximately‍‌‍‍‌‍‌‍‍‌ one out of five men will be affected by urinary tract infections (UTIs) in their lifetime. Although UTIs are quite rare in young men, the frequency of such infections increases ...